S. Africa's Aspen Pharmacare may be forced to shut down its production

Published
South Africa's Aspen Pharmacare may be forced to shut down its production of Johnson & Johnson's single-dose COVID-19 vaccines if African countries do not place orders. According to a company executive, Aspen Pharmacare has not received any orders since the company signed initial terms for a licensing deal with Johnson & Johnson late last year.

Subscribe to us on YouTube: http://ow.ly/Zvqj30aIsgY

Follow us on:

Facebook: https://www.facebook.com/cgtnafrica/
Twitter: https://twitter.com/cgtnafrica
Instagram: https://www.instagram.com/cgtn_africa/
Category
South Africa
Tags
Africa, News, south africa, Pharmacare
Be the first to comment